Beyond phenotypic differences: integrating clinical pharmacy into precision management of paediatric-onset bronchiectasis
Abstract
Extract We read with great interest the prospective multicentre study by Khalaili et al. [1], which for the first time systematically compared the clinical characteristics between paediatric-onset bronchiectasis (POBE) and adult-onset bronchiectasis (AOBE) in 1422 adult patients. This landmark study provides pivotal evidence for identifying the unique disease burden of POBE. Integrating the principles of clinical pharmacy practice and evidence-based medicine, we respectfully offer the following supplementary insights to further enhance the clinical applicability of these findings.
Fields of Study & Subjects
Cystic Fibrosis Research Advances
Pharmaceutical studies and practices
Chronic Obstructive Pulmonary Disease (COPD) Research
Publication details
- Journal / source
- European Respiratory Journal
- Volume
- 67
- Issue
- 2
- Pages
- 2501434–2501434
- Publication date
- 1 February 2026
- Language
- EN